INS and Insulin resistance: In a prospective nested case-control study, higher levels of proinsulin, a marker of peripheral insulin resistance, was found to be associated with pancreatic cancer, independent of hemoglobin A1c, suggesting that insulin resistance may be a stronger carcinogenic contributor than hyperglycemia (Wolpin et al., 2013).